187 Views

CANADIAN CARDIOVASCULAR SOCIETY

CCS

CCC

YIR

CLINICAL CARDIOLOGIST

YEAR-IN-REVIEW FOR THE CLINICAL CARDIOLOGIST: CONUNDRUMS IN GENERAL CARDIOLOGY

Q&A (CCC-169)

Saturday, October 28, 2023

10:30 – 10:45 EST

Location: Palais, 517D

Co-Chair(s)

David J. Bewick, MD, FRCPC

Associate Professor
New Brunswick Heart Center
Dalhousie University
Gillian Nesbitt, MD, FRCPC, FASE, FACC

Associate Professor
CSE
University of Toronto

Presenter(s)

Jason G. Andrade, MD

MD
CHRS
University of British Columbia
Margot K. Davis, MD, MS, FRCPC, FCCS (she/her/hers)

Clinical Associate Professor
CHFS, CCTN, CCON
University of British Columbia
Dinesh Thavendiranathan, MD, FRCPC

Director, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, TGH
Toronto General Hospital
University of Toronto

Disclosure(s):

David J. Bewick, MD, FRCPC: No financial relationships to disclose

Gillian Nesbitt, MD, FRCPC, FASE, FACC: Bristol Myers Sqibb: Speaker/Honoraria (Ongoing)

Jason G. Andrade, MD: Boston Scientific: Speaker/Honoraria (Ongoing)

Margot K. Davis, MD, MS, FRCPC, FCCS: Alnylam: Speaker/Honoraria (Ongoing); AstraZeneca: Consultant/Advisory Board (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); BI/Lilly: Consultant/Advisory Board (Ongoing); Eidos: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing); Ferring: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)

Session Description: Following the presentations, there will be a panel discussion with questions from the two co-chairs, Dr. Gillian Nesbitt and Dr. David Bewick, along with an interactive audience participation format.